Bimekizumab Tops Secukinumab for Plaque Psoriasis
In second study, bimekizumab showed noninferiority and superiority to adalimumab for moderate-to-severe disease
Millions of Americans Have Missed Their Second COVID-19 Vaccine Dose: CDC
Local health authorities struggling to make sure that those who get their first shot also get their second
AHA Offers Guidance for CVD Risk in Breast, Prostate Cancer
Patients with breast, prostate cancer who are receiving hormonal therapy more likely to develop cardiovascular risk factors
Probiotic With Low-Dose Iron Studied in Pregnant Women
Iron status improved in healthy pregnant women randomly assigned to Lactiplantibacillus plantarum 299v product versus placebo
Steroids Unrelated to Psychological Reactions in Pediatric ALL
Low-quality evidence suggests type/dose of steroid not linked to adverse psychological reactions, possibly associated with sleep problems
VTE Risk High in Cancer Patients Receiving Immune Checkpoint Inhibitors
History of VTE predicts VTE occurrence; VTE occurrence linked to increased mortality
Single-Dose Ad26.COV2.S Effective Against COVID-19
Also effective against cases in South Africa, which mainly comprised infections caused by the 20H/501Y.V2 variant
Tocilizumab Preserves Lung Function in Early Systemic Sclerosis
Stabilization of lung function independent of the extent of quantitative radiographic interstitial lung disease or fibrosis at baseline
Younger Age at First Drug Use Tied to Faster Transition to Substance Use Disorder
Past-year substance use disorder higher for adolescents than young adults at all examined time frames since first use
